肺炎球菌疫苗接种时代的小儿急性乳突炎住院趋势
该研究基于美国儿童住院数据库2000至2012年数据,分析21岁以下儿童急性乳突炎住院率趋势。结果显示2000至2012年总体住院率无显著变化,但2009至2012年间0至2岁儿童住院率下降,5岁以上儿童上升。
要点
- 2000至2012年小儿急性乳突炎总体住院率无显著下降趋势。
- 2009至2012年<1岁和1至2岁儿童住院率显著下降,可能反映13价疫苗保护作用。
- 同期5至9岁和10至20岁儿童住院率显著上升。
核心结论
- 尽管引入两种肺炎球菌疫苗,2000至2012年小儿急性乳突炎总体住院率未下降。
- 2009至2012年0至2岁儿童住院率下降,可能反映13价肺炎球菌疫苗的保护效益。
研究设计与样本
- 横断面回顾性数据分析,使用2000至2012年Kids' Inpatient Database。
- 纳入21岁以下儿童急性乳突炎诊断的全国加权住院频率。
临床怎么用
- 临床应关注肺炎球菌疫苗接种后小儿急性乳突炎住院率的变化趋势。
- 对0至2岁儿童,13价肺炎球菌疫苗可能降低急性乳突炎住院风险。
- 对5岁以上儿童,急性乳突炎住院率上升趋势需引起注意。
局限性
- 研究为横断面回顾性分析,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: The objective was to describe trends in the annual prevalence of hospitalization for pediatric acute mastoiditis since introduction of the 7-valent pneumococcal vaccine in 2000 and the 13-valent vaccine in 2010. STUDY DESIGN: Cross-sectional retrospective data analysis. METHODS: The Kids' Inpatient Database from years 2000 to 2012 was analyzed. To determine the annual prevalence of hospitalization for acute mastoiditis, nationally weighted frequencies of hospitalization for children <21 years with acute mastoiditis diagnoses were collected. Trend analysis of hospitalization rates from 2000 to -2012 was performed. RESULTS: From 2000 to 2012, there was no significant trend in hospitalization rates for acute mastoiditis overall (1.38 and 1.43 per 100,000 persons in 2000 and 2012, respectively; P = .86) or by age group. When comparing hospitalization rates at time points 2000 and 2012, children <1 year (4.65 and 3.27 per 100,000 persons, P = .0023) and 1 to 2 years of age (3.95 and 3.18 per 100,000 persons, respectively; P = .0107) demonstrated declines in hospitalization over time. Between 2009 and 2012, hospitalization rates also significantly declined for children aged <1 year (4.50 to 3.27 per 100,000 persons, P = .0056) and 1 to 2 years (4.30 to 3.18 per 100,000 persons, P = .0002) but increased for children 5 to 9 years (1.10 to 1.81 per 100,000 persons, P < .0001) and 10 to 20 years of age (0.41 to 0.72 per 100,000 persons, P < .0001). CONCLUSIONS: Despite introduction of two pneumococcal vaccines, rates of hospitalization for pediatric acute mastoiditis did not decline between 2000 and 2012. Between 2009 and 2012, however, children 0 to 2 years of age showed declining hospitalization rates, possibly reflecting the protective benefit of the 13-valent pneumococcal vaccine. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:1480-1485, 2018.
引用
- Tawfik KO, Ishman SL, Tabangin ME, et al. Pediatric acute mastoiditis in the era of pneumococcal vaccination. Laryngoscope. 2017. PMID: 29105776. doi:10.1002/lary.26968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。